Results 261 to 270 of about 81,538 (273)
Study on the molecular mechanisms of rifaximin in the treatment of non‑alcoholic steatohepatitis based on the Helicobacter‑DCA‑Fxr‑Hnf1α signalling pathway. [PDF]
Mol Med RepWan YP +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medicina Clínica (English Edition), 2022
Non-alcoholic steatohepatitis belongs to the spectrum of metabolic-associated fatty liver diseases characterized by steatosis linked to obesity, diabetes, metabolic syndrome, dyslipidemia and immune-mediated disorders. The main features of MAFLD include high prevalence, heterogeneity, complexity and dynamic disease.
openaire +4 more sources
Non-alcoholic steatohepatitis belongs to the spectrum of metabolic-associated fatty liver diseases characterized by steatosis linked to obesity, diabetes, metabolic syndrome, dyslipidemia and immune-mediated disorders. The main features of MAFLD include high prevalence, heterogeneity, complexity and dynamic disease.
openaire +4 more sources
Non‐alcoholic steatohepatitis in children
Pediatric Transplantation, 2004Abstract: Obesity has emerged as a significant new health problem in the pediatric population. Non‐alcoholic steatohepatitis (NASH) is an entity in the spectrum of non‐alcoholic fatty liver disease (NAFLD) ranges from fat in the liver – simple steatosis, NASH/ steatohepatitis – fat with inflammation and/or fibrosis to advanced fibrosis and cirrhosis ...
openaire +2 more sources
Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis
Scandinavian Journal of Gastroenterology, 2001Non-alcoholic steatohepatitis (NASH) is a form of liver disease resembling alcoholic liver disease in a patient who does not consume significant amounts of alcohol. Since its first description in 1980 it has been recognized with increasing frequency. The natural course is relatively benign, but liver cirrhosis.
openaire +3 more sources
Efruxifermin in non-alcoholic steatohepatitis
The Lancet Gastroenterology & Hepatology, 2023Sara, Mahgoub, Philip N, Newsome
openaire +2 more sources
Statins and non-alcoholic steatohepatitis
Journal of Hepatology, 2016Vasilios G, Athyros +3 more
openaire +2 more sources
[Non-alcohol steatohepatitis].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2005A Kh, Odintsova, A P, Kiiasov
openaire +1 more source
Statins and non-alcoholic steatohepatitis
Metabolism, 2017Vasilios G, Athyros +2 more
openaire +2 more sources
[Non-alcoholic steatohepatitis].
Voenno-meditsinskii zhurnal, 2006A L, Rakov +2 more
openaire +1 more source